Health Enhancement Products Inc achieves encouraging results from ongoing Bovine Mastitis study.
M2 EQUITYBITES-April 22, 2013-Health Enhancement Products Inc achieves encouraging results from ongoing Bovine Mastitis study(C)2013 M2 COMMUNICATIONS http://www.m2.com
Natural products developer Health Enhancement Products (OTCBB:HEPI) reported on Friday positive results from an ongoing bovine mastitis study conducted by Dr Laura Hernandez, a lactation expert and faculty member at the University of Wisconsin-Madison.
Dr Hernandez has been working in vitro with isolated samples of Health Enhancement Products's proprietary bioactive compounds and their effects on primary bovine mammary epithelial cells exposed to inflammatory and infective agents associated with bovine mastitis, the dairy industry's number one health and productivity issue, costing American dairy producers USD3bn annually in lost milk production and averaging 840 pounds per cow in substandard milk that must be discarded each year.
The company's in vitro test results for bovine mastitis show statistically significant results in the inhibition of TNF-a and Interleukin 1-b, as well as up-regulation of serum amyloid A, an acute phase protein secreted by the mammary gland.
According to the company, positive results were achieved for lactoferrin, a protein that inhibits the ability for bacteria to adhere to epithelial cells.
Concurrently, the test samples successfully suppressed the activity of Streptococcus uberis, a common pathogen associated with bovine mastitis, added the company.
In addition, the company principals are now conducting additional anti-inflammatory/autoimmune modulation tests using human and canine in vitro assays.
((Comments on this story may be sent to email@example.com))